| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/08916934.2014.988329 |
| P698 | PubMed publication ID | 25434364 |
| P50 | author | Blanca Fuentes | Q39051347 |
| Patricia Martínez-Sánchez | Q48671289 | ||
| P2093 | author name string | Exuperio Díez-Tejedor | |
| Dora Pascual-Salcedo | |||
| Daniel Prefasi | |||
| Ana Rodríguez-Sanz | |||
| María Jesús Blanco-Bañares | |||
| P2860 | cites work | Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke | Q28167141 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? | Q33330002 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study | Q33366716 | ||
| Antiphospholipid syndrome: role of antiphospholipid antibodies in neurology | Q33378342 | ||
| Cerebrovascular ischemic events with high positive anticardiolipin antibodies | Q33504162 | ||
| Interobserver agreement for the assessment of handicap in stroke patients. | Q34176187 | ||
| Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study | Q34619943 | ||
| Anti-beta2-glycoprotein I antibodies--when and how should they be measured? | Q35928759 | ||
| Stroke and antiphospholipid syndrome: the treatment debate | Q36102500 | ||
| Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies | Q36287542 | ||
| Antiphospholipid syndrome: laboratory testing and diagnostic strategies | Q36844544 | ||
| Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons | Q37154879 | ||
| Antiphospholipid antibodies mediate autoimmunity against dying cells | Q38109906 | ||
| Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. | Q43626449 | ||
| Antiphospholipid antibodies and stroke in young women | Q44168396 | ||
| Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. | Q45922457 | ||
| Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? | Q48021542 | ||
| IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. | Q50933721 | ||
| Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. | Q53190445 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 275-281 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Autoimmunity | Q4826348 |
| P1476 | title | Antiphospholipid antibodies correlate with stroke severity and outcome in patients with antiphospholipid syndrome | |
| P478 | volume | 48 |
Search more.